| Value | ₹50.00 Cr |
|---|---|
| Execution period | Not applicable |
NSE filing, NSE: CLEAN. Summary written from the filing by ALFA Finder's alert engine.
Clean Science & Technology Ltd: key numbers
- Share price
- ₹738.25
- Market cap
- ₹7,846 Cr
- Revenue (annual)
- ₹956.5 Cr
- Net profit (annual)
- ₹229.7 Cr
- P/E (TTM)
- 33.7×Sector 34.1×
- Promoter holding
- 51.29%+0.00% QoQ
- FII holding
- 13.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clean Science & Technology Ltd
All →Clean Science & Technology Other Announcement
Clean Science and Technology Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Clean Science & Technology Board Meeting Date
Clean Science and Technology Ltd has scheduled a board meeting for October 31, 2026, to approve unaudited financial results for the quarter and half year ending September 2026.
Clean Science & Technology Legal & Regulatory
Clean Science concluded GST proceedings, resulting in a ₹2.0 crore net financial impact. A further ₹9.9 crore liability is recoverable as Input Tax Credit.
- Value
- ₹11.90 Cr
Clean Science & Technology Credit Rating
CRISIL reaffirmed Clean Science's long-term rating at AA-/Stable and short-term at A1+. The rating action signals continued stable credit quality with no change.
Clean Science & Technology Legal & Regulatory
GST authorities initiated search and seizure proceedings at the company's premises. The company reports no material impact on financials or business operations at this stage.
Clean Science & Technology Acquisition Worth ₹50 Cr
Clean Science and Technology invested Rs. 50.00 Crore to subscribe to additional equity shares of its wholly-owned subsidiary, Clean Fino-Chem Limited, for project funding.
- Value
- ₹50.00 Cr
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr